These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Accumulation of a bone imaging agent in liver metastases from prostate carcinoma. Haseman MK. Clin Nucl Med; 1983 Oct; 8(10):488-9. PubMed ID: 6228362 [Abstract] [Full Text] [Related]
9. Radionuclide liver and bone scanning in the evaluation of patients with endometrial carcinoma. Mettler FA, Christie JH, Garcia JF, Baldwin MH, Wicks JD, Bartow SA. Radiology; 1981 Dec; 141(3):777-80. PubMed ID: 6272356 [Abstract] [Full Text] [Related]
10. High false negative rate of Tc-99m MDP whole-body bone scintigraphy in detecting skeletal metastases for patients with hepatoma. Chen CY, Wu K, Lin WH, Lan TY, Wang SY, Sun JS, Weng PW, Yen RF, Yang RS. J Formos Med Assoc; 2012 Mar; 111(3):140-6. PubMed ID: 22423667 [Abstract] [Full Text] [Related]
11. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication. Buell U, Kleinhans E, Zorn-Bopp E, Reuschel W, Muenzing W, Moser EA, Seiderer M. J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854 [Abstract] [Full Text] [Related]
12. Multiple bone metastases of hepatocellular carcinoma. Kubota T. Ann Nucl Med; 2001 Dec; 15(6):front cover, 520. PubMed ID: 11831405 [No Abstract] [Full Text] [Related]
14. Uptake of technetium-99m DISIDA by bone metastasis from a hepatoma. Pons F, Lomeña F, Calvet X, Bruix J, Catafau A, Ginés A, Herranz R, Setoain J. Clin Nucl Med; 1988 Apr; 13(4):280-2. PubMed ID: 2836119 [Abstract] [Full Text] [Related]
15. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication. Rudd TG, Allen DR, Smith FD. J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422 [Abstract] [Full Text] [Related]
16. [Clinical usefulness of 123I-IMP scintigraphy in the diagnosis of bone metastases from hepatocellular carcinoma: comparison with 99mTc-MDP bone scintigraphy]. Suto Y, Tanigawa N, Iwamiya T, Kato T, Endo K, Shabana M, Ohta Y. Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug 25; 53(8):953-9. PubMed ID: 8396760 [Abstract] [Full Text] [Related]
17. Nonvisualization of hepatoma with Tc-99m hepatobiliary agent. Lamki N, Raval B, Chamberlain M. J Nucl Med; 1981 Mar 25; 22(3):293. PubMed ID: 6259304 [No Abstract] [Full Text] [Related]
18. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer. Coleman RE, Meier CA, Rubens RD, Fogelman I. Nucl Med Commun; 1988 Jul 25; 9(7):481-5. PubMed ID: 3173907 [Abstract] [Full Text] [Related]